The effect of metabolic regulation on microvascular permeability to small and large molecules in short-term juvenile diabetics. 1976

H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen

The microvascular permeability to small and large molecules was studied during good and poor metabolic regulation in ten short duration juvenile diabetics. The following variables were measured; daily urinary albumin and beta2-microglobulin-excretion rates, whole body transcapillary escape rate of albumin (TER), glomerular filtration rate (GFR), capillary filtration coefficient (CFC), and capillary diffusion capacity (CDC). The urinary albumin and beta2-microglobulin concentration were measured by sensitive radioimmunoassays; TER was detemined from the initial disappearance of intravenously injected 125I-labelled human serum albumin; GFR was measured on the forearm by straingauge plethysmography and CDS for 51Cr-EDTA clearance; CFC was measured on the forearm by straingauge plethysmography and CDC, for 51Cr-EDTA was determined in the jyperaemic anterio tibial muscle by the local clearance technique. All the above mentioned variables, except CDC, were significantly increased during poor metabolic regulation, indicating a functional microangiopathy. The mechanisms of these alterations appear to be increased filtration pressure in the microcirculation and/or increased porosity of the microvasculature. The findings of increased microvascular albumin passage are compatible with the hypothesis that the organic - histologicallly demonstrated - diabetic microangiopathy is a long-term effect of periods of increased extravasation of plasma proteins, with subsequent protein deposition in the microvascular wall, i.e. the concept to plasmatic vasculosis.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002199 Capillary Permeability The property of blood capillary ENDOTHELIUM that allows for the selective exchange of substances between the blood and surrounding tissues and through membranous barriers such as the BLOOD-AIR BARRIER; BLOOD-AQUEOUS BARRIER; BLOOD-BRAIN BARRIER; BLOOD-NERVE BARRIER; BLOOD-RETINAL BARRIER; and BLOOD-TESTIS BARRIER. Small lipid-soluble molecules such as carbon dioxide and oxygen move freely by diffusion. Water and water-soluble molecules cannot pass through the endothelial walls and are dependent on microscopic pores. These pores show narrow areas (TIGHT JUNCTIONS) which may limit large molecule movement. Microvascular Permeability,Permeability, Capillary,Permeability, Microvascular,Vascular Permeability,Capillary Permeabilities,Microvascular Permeabilities,Permeabilities, Capillary,Permeabilities, Microvascular,Permeabilities, Vascular,Permeability, Vascular,Vascular Permeabilities
D003922 Diabetes Mellitus, Type 1 A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence. Diabetes Mellitus, Brittle,Diabetes Mellitus, Insulin-Dependent,Diabetes Mellitus, Juvenile-Onset,Diabetes Mellitus, Ketosis-Prone,Diabetes Mellitus, Sudden-Onset,Diabetes, Autoimmune,IDDM,Autoimmune Diabetes,Diabetes Mellitus, Insulin-Dependent, 1,Diabetes Mellitus, Type I,Insulin-Dependent Diabetes Mellitus 1,Juvenile-Onset Diabetes,Type 1 Diabetes,Type 1 Diabetes Mellitus,Brittle Diabetes Mellitus,Diabetes Mellitus, Insulin Dependent,Diabetes Mellitus, Juvenile Onset,Diabetes Mellitus, Ketosis Prone,Diabetes Mellitus, Sudden Onset,Diabetes, Juvenile-Onset,Diabetes, Type 1,Insulin Dependent Diabetes Mellitus 1,Insulin-Dependent Diabetes Mellitus,Juvenile Onset Diabetes,Juvenile-Onset Diabetes Mellitus,Ketosis-Prone Diabetes Mellitus,Sudden-Onset Diabetes Mellitus
D003925 Diabetic Angiopathies VASCULAR DISEASES that are associated with DIABETES MELLITUS. Diabetic Vascular Complications,Diabetic Vascular Diseases,Microangiopathy, Diabetic,Angiopathies, Diabetic,Angiopathy, Diabetic,Diabetic Angiopathy,Diabetic Microangiopathies,Diabetic Microangiopathy,Diabetic Vascular Complication,Diabetic Vascular Disease,Microangiopathies, Diabetic,Vascular Complication, Diabetic,Vascular Complications, Diabetic,Vascular Disease, Diabetic,Vascular Diseases, Diabetic
D003928 Diabetic Nephropathies KIDNEY injuries associated with diabetes mellitus and affecting KIDNEY GLOMERULUS; ARTERIOLES; KIDNEY TUBULES; and the interstitium. Clinical signs include persistent PROTEINURIA, from microalbuminuria progressing to ALBUMINURIA of greater than 300 mg/24 h, leading to reduced GLOMERULAR FILTRATION RATE and END-STAGE RENAL DISEASE. Diabetic Glomerulosclerosis,Glomerulosclerosis, Diabetic,Diabetic Kidney Disease,Diabetic Nephropathy,Intracapillary Glomerulosclerosis,Kimmelstiel-Wilson Disease,Kimmelstiel-Wilson Syndrome,Nodular Glomerulosclerosis,Diabetic Kidney Diseases,Glomerulosclerosis, Nodular,Kidney Disease, Diabetic,Kidney Diseases, Diabetic,Kimmelstiel Wilson Disease,Kimmelstiel Wilson Syndrome,Nephropathies, Diabetic,Nephropathy, Diabetic,Syndrome, Kimmelstiel-Wilson
D005260 Female Females
D005919 Glomerular Filtration Rate The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance. Filtration Rate, Glomerular,Filtration Rates, Glomerular,Glomerular Filtration Rates,Rate, Glomerular Filtration,Rates, Glomerular Filtration
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
January 1976, Diabetes,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
January 1986, Bulletin europeen de physiopathologie respiratoire,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
January 1983, European journal of respiratory diseases. Supplement,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
December 1981, The American journal of physiology,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
April 1999, Advanced drug delivery reviews,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
January 1996, Vnitrni lekarstvi,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
February 1986, Federation proceedings,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
January 1980, Acta medica Scandinavica. Supplementum,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
August 1978, Journal of human nutrition,
H H Parving, and I Noer, and T Deckert, and P E Evrin, and S L Nielsen, and J Lyngsoe, and C E Mogensen, and M Rorth, and P A Svendsen, and J Trap-Jensen, and N A Lassen
November 2013, Regulatory toxicology and pharmacology : RTP,
Copied contents to your clipboard!